 Thomas Bak
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 22 | 2022 | 871 | 0.930 |
Why?
| | Living Donors | 8 | 2022 | 295 | 0.350 |
Why?
| | Hepatic Artery | 3 | 2004 | 62 | 0.290 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2007 | 362 | 0.230 |
Why?
| | Duodenal Diseases | 1 | 2004 | 8 | 0.230 |
Why?
| | Intestinal Fistula | 1 | 2004 | 17 | 0.230 |
Why?
| | Vascular Fistula | 1 | 2004 | 23 | 0.230 |
Why?
| | Aneurysm, False | 1 | 2004 | 48 | 0.220 |
Why?
| | Immunosuppressive Agents | 8 | 2008 | 890 | 0.200 |
Why?
| | Liver Neoplasms | 5 | 2007 | 786 | 0.190 |
Why?
| | Cholangitis, Sclerosing | 4 | 2008 | 75 | 0.160 |
Why?
| | Sirolimus | 3 | 2007 | 276 | 0.120 |
Why?
| | Donor Selection | 1 | 2016 | 77 | 0.120 |
Why?
| | Liver Failure | 2 | 2008 | 94 | 0.120 |
Why?
| | Airway Extubation | 1 | 2016 | 57 | 0.120 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 157 | 0.110 |
Why?
| | Cholestasis | 1 | 2016 | 235 | 0.100 |
Why?
| | Tissue Donors | 1 | 2016 | 425 | 0.100 |
Why?
| | Graft Rejection | 3 | 2007 | 624 | 0.090 |
Why?
| | Tacrolimus | 3 | 2007 | 199 | 0.080 |
Why?
| | Graft Survival | 5 | 2016 | 535 | 0.080 |
Why?
| | Hypoxia | 1 | 2016 | 1112 | 0.070 |
Why?
| | Hepatitis, Autoimmune | 1 | 2008 | 20 | 0.070 |
Why?
| | Hepatic Veins | 1 | 2008 | 33 | 0.070 |
Why?
| | Cadaver | 3 | 2004 | 296 | 0.070 |
Why?
| | Chemoembolization, Therapeutic | 2 | 2007 | 91 | 0.070 |
Why?
| | Hepatectomy | 1 | 2008 | 251 | 0.060 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 44 | 0.060 |
Why?
| | Disease Transmission, Infectious | 1 | 2006 | 62 | 0.060 |
Why?
| | Bile Ducts | 2 | 2022 | 71 | 0.060 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2022 | 28 | 0.060 |
Why?
| | Herpes Simplex | 1 | 2006 | 95 | 0.060 |
Why?
| | Portal Vein | 1 | 2006 | 120 | 0.060 |
Why?
| | Tissue and Organ Procurement | 3 | 2004 | 321 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 565 | 0.060 |
Why?
| | Venous Thrombosis | 1 | 2006 | 190 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2004 | 71 | 0.050 |
Why?
| | Middle Aged | 15 | 2016 | 33479 | 0.050 |
Why?
| | Survival Analysis | 4 | 2008 | 1325 | 0.050 |
Why?
| | Reoperation | 3 | 2016 | 573 | 0.050 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.050 |
Why?
| | Hepatocytes | 1 | 2003 | 220 | 0.050 |
Why?
| | Hospital Costs | 1 | 2003 | 117 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2016 | 10811 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2004 | 303 | 0.040 |
Why?
| | Humans | 23 | 2022 | 137585 | 0.040 |
Why?
| | Adult | 11 | 2016 | 37929 | 0.040 |
Why?
| | Pancreas Transplantation | 1 | 2000 | 75 | 0.040 |
Why?
| | Hepatitis C | 1 | 2003 | 271 | 0.040 |
Why?
| | Female | 16 | 2016 | 73304 | 0.040 |
Why?
| | Retrospective Studies | 8 | 2016 | 15657 | 0.040 |
Why?
| | Recurrence | 3 | 2008 | 1060 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 594 | 0.040 |
Why?
| | Male | 16 | 2016 | 67762 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2008 | 686 | 0.030 |
Why?
| | Time Factors | 3 | 2016 | 6828 | 0.030 |
Why?
| | Shock | 1 | 2016 | 98 | 0.030 |
Why?
| | Risk Factors | 4 | 2016 | 10388 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2016 | 194 | 0.030 |
Why?
| | Cause of Death | 1 | 2016 | 434 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 353 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2008 | 5131 | 0.030 |
Why?
| | Health Care Rationing | 2 | 2004 | 59 | 0.030 |
Why?
| | Cyclosporine | 2 | 2003 | 268 | 0.020 |
Why?
| | Neoplasm Staging | 2 | 2007 | 1389 | 0.020 |
Why?
| | Cohort Studies | 3 | 2008 | 5742 | 0.020 |
Why?
| | Patient Selection | 2 | 2004 | 696 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1943 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 70 | 0.020 |
Why?
| | Functional Laterality | 1 | 2008 | 223 | 0.020 |
Why?
| | Portography | 1 | 2006 | 12 | 0.020 |
Why?
| | Adolescent | 3 | 2016 | 21513 | 0.020 |
Why?
| | Ultrasonics | 1 | 2006 | 49 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2007 | 181 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2006 | 2691 | 0.020 |
Why?
| | Simplexvirus | 1 | 2006 | 80 | 0.020 |
Why?
| | Blood Vessels | 1 | 2007 | 187 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2007 | 510 | 0.010 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 889 | 0.010 |
Why?
| | Treatment Failure | 1 | 2006 | 356 | 0.010 |
Why?
| | Colorado | 2 | 2008 | 4565 | 0.010 |
Why?
| | Safety | 1 | 2007 | 338 | 0.010 |
Why?
| | Elective Surgical Procedures | 1 | 2006 | 179 | 0.010 |
Why?
| | Preoperative Care | 1 | 2007 | 362 | 0.010 |
Why?
| | Biomarkers | 1 | 2016 | 4149 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2008 | 1266 | 0.010 |
Why?
| | Survival | 1 | 2004 | 38 | 0.010 |
Why?
| | Waiting Lists | 1 | 2006 | 266 | 0.010 |
Why?
| | Transplants | 1 | 2004 | 36 | 0.010 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 46 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2000 | 3715 | 0.010 |
Why?
| | Aged | 3 | 2008 | 23961 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2003 | 86 | 0.010 |
Why?
| | Muromonab-CD3 | 1 | 2003 | 20 | 0.010 |
Why?
| | Cost Control | 1 | 2003 | 39 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2003 | 148 | 0.010 |
Why?
| | Outpatients | 1 | 2006 | 396 | 0.010 |
Why?
| | Cost Savings | 1 | 2003 | 84 | 0.010 |
Why?
| | Hospitals, University | 1 | 2003 | 182 | 0.010 |
Why?
| | Ultrasonography | 1 | 2006 | 759 | 0.010 |
Why?
| | Aspartate Aminotransferases | 1 | 2002 | 90 | 0.010 |
Why?
| | Postoperative Complications | 2 | 2004 | 2654 | 0.010 |
Why?
| | Alanine Transaminase | 1 | 2002 | 157 | 0.010 |
Why?
| | Child | 2 | 2016 | 21935 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1079 | 0.010 |
Why?
| | Incidence | 1 | 2007 | 2804 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2003 | 1509 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 13209 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3457 | 0.010 |
Why?
| | Liver Failure, Acute | 1 | 1998 | 67 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 1998 | 153 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2031 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 2057 | 0.010 |
Why?
| | Age Factors | 1 | 2004 | 3295 | 0.010 |
Why?
| | Prevalence | 1 | 2003 | 2734 | 0.010 |
Why?
| | Models, Biological | 1 | 2003 | 1783 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2828 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2003 | 1040 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3566 | 0.010 |
Why?
| | Obesity | 1 | 2003 | 2992 | 0.000 |
Why?
| | Child, Preschool | 1 | 2004 | 11074 | 0.000 |
Why?
|
|
Bak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|